Biological Mimetics, Inc.
Frederick, MD Doing business as Biological Mimetics Inc.
- UEI
- LJARDLY9MMK5
- CAGE
- 3FN24
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Biological Mimetics, Inc.
LJARDLY9MMK5
- Micocalo LLC HEQ7AW5KUFM9
-
Biological Mimetics, Inc.
LJARDLY9MMK5
- SAM.gov registration date
- Physical address
- 124 Byte Dr, Frederick, MD 21702, USA
- Website
- biologicalmimetics.com
- Founded
- 1996
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Phase II sbir biological mimetics, INC. Award | National Institute of Allergy and Infectious Diseases | $1,498,641 | |
| A subunit vaccine against acinetobacter baumannii - project title: development of a novel vaccine against multi-drug… | National Institute of Allergy and Infectious Diseases | $854,682 | |
| An instrument-free malaria diagnostic - abstract we propose to develop a sensitive, rapid, and affordable crispr-based… | National Institute of Allergy and Infectious Diseases | $588,900 | |
| Development of a staph aureus vaccine - abstract methicillin-resistant staphylococcus aureus is often considered the… | National Institute of Allergy and Infectious Diseases | $592,884 | |
| Phase i sbir biological mimetics, INC. Award | National Institute of Allergy and Infectious Diseases | $299,820 |
About Biological Mimetics, Inc.
Biological Mimetics, Inc. is a biotechnology firm located in Frederick, Maryland, specializing in developing advanced diagnostic technologies, vaccines, and innovative solutions for infectious diseases and public health challenges. Registered in SAM.gov since 2003, the company operates as a for-profit corporate entity with a focus on research and development in emerging medical technologies. The firm actively participates in federal contract and grant programs, particularly through Small Business Innovation Research (SBIR) mechanisms, demonstrating expertise in developing specialized diagnostic and vaccine technologies for challenging medical conditions.
Through federal contract awards, Biological Mimetics, Inc. has primarily engaged in SBIR-funded projects with the National Institute of Allergy and Infectious Diseases (NIAID). The company has received a significant Phase II SBIR contract valued at $1,498,641 for developing a CRISPR-based diagnostic test for parasites, with a completion date of September 14, 2028. This contract is set aside for small businesses and represents the company's continued work in advanced diagnostic technology development. The contract is a Firm Fixed Price agreement focused on creating innovative diagnostic solutions that can potentially transform parasitic disease detection methods.
On the federal grant side, Biological Mimetics, Inc. has been awarded multiple project grants from NIAID focusing on vaccine development and diagnostic technologies. These grants include a project to develop a novel vaccine candidate against multi-drug resistant Acinetobacter baumannii, a vaccine development project for Staphylococcus aureus, and a grant to create an instrument-free malaria diagnostic test. Additionally, the company received a grant from the Institute of Food Production and Sustainability to develop an improved PCV2 vaccine for the pork industry. These grants, ranging from approximately $288,360 to $300,000, demonstrate the company's broad capabilities in developing innovative solutions for infectious diseases, animal health, and diagnostic technologies across multiple domains.
SBA capabilities narrative
BMI offers scientific services and biomedical reagents. Services include gene expression, virology, immunology, molecular biology, and vaccine design and development.
Quick answers
What is Biological Mimetics, Inc.'s UEI?
Biological Mimetics, Inc.'s Unique Entity ID (UEI) in SAM.gov is LJARDLY9MMK5.
What is Biological Mimetics, Inc.'s CAGE code?
Biological Mimetics, Inc.'s CAGE code is 3FN24.
What is Biological Mimetics, Inc.'s primary NAICS code?
Biological Mimetics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Biological Mimetics, Inc. located?
Biological Mimetics, Inc.'s physical address in SAM.gov is 124 Byte Dr, Frederick, MD 21702, USA.
Is Biological Mimetics, Inc. registered in SAM.gov?
Yes. Biological Mimetics, Inc.'s SAM.gov registration is active through May 7, 2027.
What is Biological Mimetics, Inc.'s most recent federal award?
Biological Mimetics, Inc.'s most recent federal contract award is Phase II sbir biological mimetics, INC. Award (75N93025C00031), from National Institute of Allergy and Infectious Diseases, on September 15, 2025.
On GovTribe
See Biological Mimetics, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors